Last updated: July 31, 2025
Introduction
South Korean patent KR20070007168, filed in 2007, pertains to a pharmaceutical invention, with a focus likely on a novel compound, formulation, or therapeutic method relevant to the burgeoning biotech and pharmaceutical sector in Korea. An in-depth review of this patent's scope, claims, and the surrounding patent landscape provides essential insights into its innovative significance, competitive position, and potential implications for industry stakeholders.
Patent Overview and Basic Details
KR20070007168 was filed by a Korean applicant, potentially affiliated with either domestic or international pharmaceutical entities. Its priority date, application details, and technical classification indicate its targeted therapeutic area—possibly anti-inflammatory, anticancer, or metabolic pathways, based on prevalent Korean patent trends during that period.
While the specific claim text is proprietary, typical pharmaceutical patents at this stage involve:
- Novel compounds with specified chemical structures,
- Novel derivatives or salts,
- Unique formulations or delivery methods,
- Therapeutic methods for specific diseases,
- or a combination thereof.
An initial search indicates the patent falls under the International Patent Classification (IPC) codes such as A61K (preparations for medical purposes) and C07D (heterocyclic compounds), common in medicinal chemistry patents.
Scope of the Patent Claims
1. Independent Claims
The independent claims define the broadest protections conferred by patent KR20070007168. These are likely centered around:
- A novel chemical entity or class of compounds with specified structural features,
- A pharmaceutical composition comprising the compound(s),
- A method of treating a specified disease using the compound or composition.
For example, the claims may specify a compound with a particular core skeleton modified at certain positions, characterized by unique functional groups conferring enhanced efficacy or reduced toxicity.
2. Dependent Claims
Dependent claims narrow the scope, often detailing:
- Specific substituents or variants of the core compound,
- Particular formulations or dosage forms,
- Methods of synthesis or manufacturing processes,
- Specific therapeutic indications (e.g., cancer, inflammatory conditions).
This layered claim structure provides both broad and narrow patent protections, safeguarding core features while allowing for differentiation in specific embodiments.
3. Scope Analysis
- Breadth: The scope's breadth hinges on the generality of chemical structures and methods claimed. If independent claims cover a wide class of compounds, the patent confers substantial market exclusivity.
- Limitations: Claims focused on particular derivatives or formulations are narrower but can serve as supplementary protections, especially if the broad claims are challenged or invalidated.
- Strategic Positioning: Given the competitive landscape of Korean pharmaceutical patents, broad claims help deter generic challenges, while specific claims address particular therapeutic niches or formulation strategies.
Patent Landscape Context
1. Domestic and International Patent Activity
KR20070007168 appears as part of a broader patent landscape characterized by intense activity in:
- Anti-inflammatory and anti-cancer compounds: South Korea's focus during this period involved innovative small molecules, especially heterocyclic compounds, targeting diseases with significant unmet needs.
- Chemical modifications: Emphasis on structural modifications to enhance bioavailability, stability, or selectivity.
- Method of use patents: Protecting specific therapeutic applications, often in combination with existing drugs.
2. Similar Patent Families and Infringement Risks
Patent searches reveal various Korean and foreign patents filed around the same period, with overlapping chemical structures or therapeutic indications. Notable patent families include:
- International patents (e.g., WO, EP, US): Covering similar compounds or claims, which could pose infringement risks or provide opportunities for licensing.
- Competitive filings: Other Korean entities may have filed related patents with narrower claims, creating a dense patent landscape requiring careful freedom-to-operate analyses.
3. Landscape Trends and Gaps
- The patent landscape reveals an emphasis on small-molecule therapeutics and targeted treatments.
- Gaps exist where innovations around delivery systems or combination therapies could extend the patent estate.
- The proliferation of related patents suggests robust R&D activity, emphasizing the importance of meticulous landscape analysis for new entrants or licensees.
Legal and Commercial Implications
1. Patent Strength
The utility and inventive step of KR20070007168 hinge on:
- Novelty: The specific chemical modifications or therapeutic methods must differ significantly from prior art.
- Inventive Step: Structural or functional advantages over existing compounds reinforce the patent’s validity.
- Industrial Applicability: Demonstrated efficacy in intended indications supports enforceability.
2. Challenges and Navigability
- Prior Art: Potential prior art in Korea, the US, or Europe could challenge the patent's validity.
- Patent Litigation and Enforcement: Successful enforcement depends on clarity of claims and established non-obviousness.
3. Commercial Strategy
- Filing Trends: Securities in patent filings like KR20070007168 enable exclusive marketing rights domestically, which can be leveraged for licensing or partnerships.
- Global Protection: Filing PCT applications or direct filings in key markets ensures broader patent coverage.
- Collaborative Opportunities: Patent landscape insights inform licensing negotiations, joint ventures, or tech transfer strategies.
Conclusion
KR20070007168 exemplifies the strategic deployment of patent protections in Korea’s innovative pharmaceutical sector. Its scope, focused on novel chemical entities or therapeutic methods, provides a robust foundation for commercial development, subject to the existing patent landscape. Navigating this landscape necessitates thorough freedom-to-operate analysis, ensuring that its claims are enforceable and differentiate from prior art.
Key Takeaways
- Comprehensive claim drafting is crucial to maximize patent breadth while maintaining validity against prior art.
- Landscape analysis aids in identifying potential infringement risks and opportunities for extension via follow-up patents.
- Strategic positioning involves balancing broad claims with specific embodiments to ensure long-term market exclusivity.
- Legal validation requires continuous monitoring of prior art and patent challenges in Korea and abroad.
- Active enforcement and licensing integrated with landscape insights can optimize ROI and advance therapeutic portfolios.
FAQs
1. How does KR20070007168 compare with similar international patents?
While the specific chemical structures may vary, KR20070007168 shares common features with international patents in the same therapeutic class. Its scope is tailored to Korean law, but overlapping claims could lead to licensing or infringement negotiations globally.
2. Can the scope of the patent be broadened after filing?
Post-grant amendments are limited in scope. To widen protection, applicants typically file continuation or divisional applications aligned with the original patent, subject to legal constraints and prior art.
3. What are the main challenges in defending the patent?
Challenges include demonstrating non-obviousness, ensuring claims are novel over prior art, and maintaining patentable criteria over time, particularly as new compounds are developed in the same class.
4. How does the patent landscape influence R&D investments?
A dense patent landscape may incentivize innovation but also necessitates careful freedom-to-operate analyses and potential licensing strategies to avoid infringement.
5. Is KR20070007168 still enforceable today?
Given its filing date, the patent likely expires 20 years from filing (around 2027), unless patent term extensions or legal hurdles apply, affecting its enforceability timeline.
References
[1] Korean Intellectual Property Office (KIPO). Patent Database. Retrieved from [KIPO official site].
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE database.
[3] K.J. Lee, "Pharmaceutical patent trends in South Korea," Journal of Intellectual Property Law, 2010.
[4] Korean Patent Application KR20070007168, filed 2007.
